Published on
01:45 GMT
Myung In Pharm bucks Korea’s pharma slump with $60 mil. profit ahead of Kospi debut
As most Korean pharma firms slogged through another year of margin compression, Myung In Pharm posted 90.1 billion won ($61.2 million) in operating profit and kept its debt ratio under 10 percent last year. Just seven drugmakers in the country cleared that …
Source:
Korea Biomedical Review
-
Neutral
.png&h=630&w=1200&q=100&v=5f99a4b43f&c=1)
